All lobbying filings

W STRATEGIES, LLC

Lobbying for ABBOTT LABORATORIES · A pharmaceuticals health care company.

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 1

HOUSE OF REPRESENTATIVES

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 1

HR 2300
To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other pu…

Lobbying activity 1

Health Issues

Issues related to infant formula access. Issues related to DMEPOS reimbursement by CMS. H.R.2300 - To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.